Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 2, 2011, Pages 208-212

  Warne, Nicholas W ^a  

^a PFIZER INC   (United States)

Author keywords

Dosage form; Efficiency; Formulation; Monoclonal antibody; Platform; Protein

Indexed keywords

ABCIXIMAB; ADALIMUMAB; ALEMTUZUMAB; BASILIXIMAB; BEVACIZUMAB; CANAKINUMAB; CETUXIMAB; DACLIZUMAB; ECULIZUMAB; EFALIZUMAB; GOLIMUMAB; INFLIXIMAB; MONOCLONAL ANTIBODY; OFATUMUMAB; OMALIZUMAB; PALIVIZUMAB; PANITUMUMAB; PROTEIN A; RANIBIZUMAB; RITUXIMAB; SUCROSE; TOCILIZUMAB; TRASTUZUMAB; TREHALOSE; USTEKINUMAB;

AFFINITY CHROMATOGRAPHY; BIOTECHNOLOGY; CLINICAL TRIAL; CRYOPROTECTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; FREEZE DRYING; HUMAN; IONIC STRENGTH; NOTE; PH; PHASE 3 CLINICAL TRIAL (TOPIC); PHASE PARTITIONING; SCIENTIST;

EID: 79955796129     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.03.004     Document Type: Article

References (17)

1. S. Martin-Moe, T. Osslund, Y.J. Wang, T. Mahmood, R. Deshpande, S. Hershenson, The structure of biological therapeutics, in: F. Jameel, S. Hershenson (Eds.), Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals, John Wiley and Sons Inc., pp. 3-40.
2. FDA, Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products, FDA Report, March 2004.
3. Editorial: Raising the game, Nature Biotechnology (2008) 137.
4. R. Osborne, Fresh from the biologic popeline, Nature Biotechnology (2009) 223-225.
5. B. Hughes, 2007 FDA Drug Approvals: A Year of Flux, Nature Reviews Drug Discovery (2008) 107-109.
6. A. Salmen, K. Lindgren, L. Bylund, G. Gelius, C. Fenge, U. Skiging-Nyberg, Efficient development of stable high-titer cell lines for biopharmaceutical manufacturing, BioProcess International (2009) 34-44.
7. N. Tugcu, D.J. Roush, K.E. Göklen, Maximizing productivity of chromatography steps for purification of monoclonal antibodies, Biotechnology and Bioengineering 99 (2008) 599-613. (Pubitemid 351158258)
8. B.D. Kelley, S.A. Tobler, P. Brown, J.L. Coffman, R. Godavarti, T. Iskra, M. Switzer, S. Vunnum, Weak partitioning chromatography for anion exchange purification of monoclonal antibodies, Biotechnology and Bioengineering 101 (2008) 553-566.
9. M.A.H. Capelle, R. Gurny, T. Arvinte, High throughput screening of protein formulation stability: practical considerations, European Journal of Pharmaceutics and Biopharmaceutics (2007) 131-148. (Pubitemid 46038086)
10. D. Das, Early stage protein formulation development and use of high throughput screening methods, in: Proceedings of the AAPS National Biotechnology Conference, San Diego, CA, June 24-27, 2007.
11. M.C. Manning, K. Patel, R.T. Borchardt, Stability of protein pharmaceuticals, Pharmaceutical Research 6 (1989) 903-918. (Pubitemid 20078439)
12. J.F. Carpenter, M.J. Pikal, B.S. Chang, T.W. Randolph, Rational design of stable lyophilized protein formulations: some practical advice, Pharmaceutical Research 14 (1997) 969-975. (Pubitemid 27371393)
13. B.S. Chang, B.S. Kendrick, J.F. Carpenter, Surface-induced denaturation of proteins during freezing and its inhibition by surfactants, Journal of Pharmaceutical Sciences 85 (1996) 1325-1330. (Pubitemid 27014188)
14. I.C.H. Harmonized, Tripartate guideline on pharmaceutical development Q8, Step 4 version dated 10 November 2005.
15. S.D. Allison, T.W. Randolph, M.C. Manning, K. Middleton, A. Davis, J.F. Carpenter, Effects of drying methods and additives on structure and function of actin: mechanisms of dehydration-induced damage and its inhibition, Archives of Biochemistry and Biophysics 358 (1998) 171-181. (Pubitemid 28471387)
16. G.W. Farr, J.R. Heitz, Imidazole catalysis of sucrose hydrolysis, Journal of Dental Research 53 (1974) 516-519.
17. K. Ho, J. Linton, A. Kantor, D. Dixon, S. Tschessalov, S. Knowles, N. Warne, Membrane preference during protein sterile filtration: adsorption studies, AAPS Biotechnology Conference, Boston, June 2004